Related references
Note: Only part of the references are listed.Having Pancreatic Cancer with Tumoral Loss of ATM and Normal TP53 Protein Expression Is Associated with a Poorer Prognosis
Haeryoung Kim et al.
CLINICAL CANCER RESEARCH (2014)
Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs
Daisuke Hashimoto et al.
EUROPEAN JOURNAL OF CANCER (2014)
Autophagy, p53, and Pancreatic Cancer
Christine A. Iacobuzio-Donahue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma
Brian M. Wolpin et al.
ONCOLOGIST (2014)
Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine
Daniela Laura Papademetrio et al.
TARGETED ONCOLOGY (2014)
Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations
Annan Yang et al.
CANCER DISCOVERY (2014)
Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
Minoru Oshima et al.
ANNALS OF SURGERY (2013)
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
Todd M. Bauer et al.
CANCER (2013)
Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus
Yoko Momose et al.
JOURNAL OF DERMATOLOGY (2013)
CANCER A suppression switch
Hanna Starobinets et al.
NATURE (2013)
p53 status determines the role of autophagy in pancreatic tumour development
Mathias T. Rosenfeldt et al.
NATURE (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model
Elizabeth Donohue et al.
JOURNAL OF CANCER (2013)
Microscopic Margins and Patterns of Treatment Failure in Resected Pancreatic Adenocarcinoma
Jennifer L. Gnerlich et al.
ARCHIVES OF SURGERY (2012)
AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway
Rui Kang et al.
AUTOPHAGY (2012)
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky et al.
AUTOPHAGY (2012)
Cell-Mediated Autophagy Promotes Cancer Cell Survival
William J. Buchser et al.
CANCER RESEARCH (2012)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno et al.
CELL (2012)
Autophagic activity dictates the cellular response to oncogenic RAS
Yihua Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia
Rui Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Apoptosis to autophagy switch triggered by the MHC class III-encoded receptor for advanced glycation endproducts (RAGE)
Rui Kang et al.
AUTOPHAGY (2011)
A critical role for autophagy in pancreatic cancer
Shenghong Yang et al.
AUTOPHAGY (2011)
RAGE regulates autophagy and apoptosis following oxidative injury
Rui Kang et al.
AUTOPHAGY (2011)
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
Erkan Topkan et al.
BMC GASTROENTEROLOGY (2011)
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Ravi K. Amaravadi et al.
CLINICAL CANCER RESEARCH (2011)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang et al.
GENES & DEVELOPMENT (2011)
Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma
Olga K. Mirzoeva et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy
Nazik Hammad et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2010)
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2010)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma
Philip Bao et al.
HPB (2009)
Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells
Satoshi Fujii et al.
CANCER SCIENCE (2008)
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis
T Munster et al.
ARTHRITIS AND RHEUMATISM (2002)
Share Paper
